It was suggested that cathepsin B (CTSB) released from the lysosomes after RD‐N treatment triggered apoptosis in prostate cancer (PCa) cells,1 but the underlying molecular mechanisms responsible for the effects remained unknown. The gene discussed is CTSB; the disease is posterior cortical atrophy.